This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44754239
rdf:type
wikibase:Item
schema:description
articol științific 2004 nî lūn-bûn article scientific scientific article published in July 2004 artigo científico научна статия 2004年學術文章 wetenschappelijk artikel 2004年学术文章 artikull shkencor مقالة علمية نشرت في يوليو 2004 artykuł naukowy מאמר מדעי vetenskaplig artikel tieteellinen artikkeli научни чланак научни чланак vedecký článok სამეცნიერო სტატია scienca artikolo vitskapeleg artikkel 2004年の論文 επιστημονικό άρθρο জুলাই ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published in July 2004 2004年學術文章 2004年学术文章 artigo científico 2004年學術文章 2004년 논문 bài báo khoa học vědecký článek научная статья บทความทางวิทยาศาสตร์ 2004年学术文章 artikulong pang-agham articolo scientifico scientific article published in July 2004 artículu científicu мақолаи илмӣ bilimsel makale article scientifique vitenskapelig artikkel naučni članak 2004年学术文章 tudományos cikk videnskabelig artikel artikel ilmiah 2004年学术文章 наукова стаття, опублікована в липні 2004 wissenschaftlicher Artikel 2004年學術文章 teaduslik artikkel article científic artigo científico artículo científico publicado en 2004 2004年學術文章 2004年学术文章
p:P577
wds:Q44754239-51397A78-7655-4A25-BF57-47FC48F2E5D9
wdt:P577
2004-07-01T00:00:00Z
p:P2860
wds:Q44754239-000DC2A4-5433-4E6F-87BA-894963F679B2 wds:Q44754239-29D93C06-9BB8-402A-B869-BD23B8821475 wds:Q44754239-3F760943-DD7B-4BCD-8D6D-8EAF1D270BD0 wds:Q44754239-4E59C510-A661-4282-A486-182086428116 wds:Q44754239-6851AD5D-3BAC-4B0C-81C5-297E8F7A0D47 wds:Q44754239-81A7E3F9-837D-4CDA-AC9E-8782B5614D34 wds:Q44754239-8518A757-176A-472E-A135-31693FB95D3E wds:Q44754239-85F55A05-18BD-4441-A6B6-800E3F1A1CBD wds:Q44754239-9768C148-B0AA-42C2-A86E-7E000CC8D9CC wds:Q44754239-97D073EE-24E7-4EB9-B842-FF4BB989FDB1 wds:Q44754239-9805DBD9-9415-47BF-8E50-67207ABA759E
wdt:P2860
wd:Q44475102 wd:Q45746500 wd:Q33595278 wd:Q39653073 wd:Q39684211 wd:Q44087380 wd:Q34147253 wd:Q43896562 wd:Q56101159 wd:Q44305153 wd:Q33981100
p:P2093
wds:Q44754239-FF5EFA6D-56A7-4838-8069-E8E54509F66F wds:Q44754239-F97A0272-B2BD-4F9C-8DBD-00F204AEDCC7 wds:Q44754239-DD29501B-9316-4F25-9EE1-319D7EDE2AC1 wds:Q44754239-CDE9ED23-C625-4D22-B934-17F1F7E78D40 wds:Q44754239-9AE6B28A-2EC8-405A-9099-12C82F0C8BD1 wds:Q44754239-231A4D5A-ACD7-42DA-9307-BB46C521F2CB wds:Q44754239-02CD70D9-1BD1-470B-9955-F10B69132150
wdt:P2093
C Katlama A M Cattelan N Clumeck R de J Pedro P Tymkewycz R Thomas C Zhu
rdfs:label
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults. A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.
skos:prefLabel
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults. A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.
schema:name
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults. A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.
p:P50
wds:Q44754239-56AABAA6-DCD6-41D4-8265-DD5BD6F7D304 wds:Q44754239-D3632FFB-BA4B-4D8E-B409-5BF6C3AE3F31
wdt:P50
wd:Q45357574 wd:Q57008013
p:P1476
wds:Q44754239-FCB373B0-125E-448F-82E9-ED2E3783BF08
wdt:P1476
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults
p:P304
wds:Q44754239-FDA2EA72-B141-48A8-85EB-E6399BD98BC1
wdt:P304
296-302
p:P31
wds:Q44754239-C70A6B90-30D5-4013-BD67-22525A3537C2
wdt:P31
wd:Q13442814
p:P921
wds:Q44754239-4D64A566-4640-426E-8902-6685D02AB49C
wdt:P921
wd:Q422618
p:P698
wds:Q44754239-1FBE481C-24CC-45F3-B615-008526C6DC2A
wdtn:P698
n12:15236620
wdt:P698
15236620
p:P1433
wds:Q44754239-CB018009-B273-477E-BA49-EC50E04AE586
wdt:P1433
wd:Q15756376
p:P433
wds:Q44754239-F7756D36-5964-48EB-B77C-B958381628AA
p:P478
wds:Q44754239-A78DDF1A-4E9F-4212-91F2-0A934519177F
wdt:P433
4
wdt:P478
5
p:P356
wds:Q44754239-EDE46820-8481-43B2-A1FA-B572C7A5DAB3
wdtn:P356
n11:J.1468-1293.2004.00224.X
wdt:P356
10.1111/J.1468-1293.2004.00224.X
p:P5875
wds:Q44754239-F36DF1FD-CF4C-4311-8419-A78501E6ECEA
wdt:P5875
8471632